• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OSX
Click for more information
12.5% 13.5¢

OSTEOPORE LIMITED - Charts / Financials

Market Cap $1.343M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Instruments & Supplies

Osteopore Limited is an Australia-based medical technology company. The Company is... Osteopore Limited is an Australia-based medical technology company. The Company is engaged in commercializing a range of bespoke products specifically engineered to facilitate bone healing across multiple therapeutic areas. The Company’s patented technology fabricates specific micro-structured scaffolds for bone regeneration through three-dimensional (3D) printing and bioresorbable material. The Company’s Osteoplug in plug and strip configuration fills craniotomy gaps effortlessly. It also promotes bone tissue integration, from the skull to the bone flap. Its craniofacial products include Osteomesh, Osteoplug, and Osteoplug-C. It also offers craniotomy, orbital floor reconstruction, socket preservation, cranioplasty patient-specific implants (PSI), craniosynostosis, guided bone regeneration, minimally invasive skull base surgery, endoscopic transsphenoidal skull base surgery, burr hole restoration with the shunt drainage system, mandible PSI, immediate implant loading, and more.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 10.06am 18/04/2024 (20 minute delay) ?
Day
Open 13.0¢   Day High 14.0¢   Day Low 13.0¢
Daily Volume 46072
Bids   Sellers
Number Price Volume   Number Price Volume
1 13.5¢ 8122   1 14.0¢ 4264

Directors & Senior Management

Mr. Mark Leong Executive Chairman of the Board
Dr. Lim Jing Chief Executive Officer
Mr. Carl Runde Chief Financial Officer
Mrs. Kellie Davis Company Secretary
Mr. Michael Keenan Non-Executive Director
Prof. Teoh Swee Hin Non-Executive Director
Mr. Daniel Ow Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
13.5¢ 		Change
0.015(12.5%) 		Mkt cap ! $1.343M
Open High Low Value Volume
13.0¢ 14.0¢ 13.0¢ $6.139K 46.07K

Buyers (Bids)

No. Vol. Price($)
1 8122 13.5¢
 

Sellers (Offers)

Price($) Vol. No.
14.0¢ 4264 1
View Market Depth
Last trade - 12.33pm 18/04/2024 (20 minute delay) ?

Top Stories

Chariots of fire on pole to meet resurgent US lithium security focus.

Chariot Corporation is a company in a hurry.Since listing on the Australian stock exchange (ASX) in October, Chariot’s focus has been on building up a significant suite of lithium projects across three US states with the goal of securing future supply of the mineral to fulfil a vo...
Canada's Hillcrest Energy (CSE.HEAT) partners with BC's Powertech Labs Canada-based Hillcrest Energy Technologies has teamed up with British Columbia-based Powertech Labs to test Hillcrest's ZVS technology.
Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold Depending on what interests you more, there were two big stories this week for the international finance space.
Market Update: Energy keeps light bright in a sea of red The ASX is down .7 of a per cent with every sector - except energy - in the red and real estate diving nearly 2 per cent mid-session.
Recce Pharmaceuticals up 6% on new antibiotic production milestone Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.